| Application no. and date | 12782600.6 (espacenet) (Federated) (European Patent Register), 20120514 | | Patent/reg. no. and date | DK/EP 2707003, 20190501 | | Publication date | 20140319 | | Priority no. and date | US 201161485179 P, 20110512 | | EP pub. no. and date |
EP 2707003 20140319 | | Effective date | | | Applicant/owner | Allergan Pharmaceuticals International Limited, Clonshaugh Industrial Estate
Coolock
Dublin 17, IE,
Paratek Pharmaceuticals, Inc., 75 Park Plaza
Boston, MA 02116, US | | Applicant ref. no. | P69112DK01 | | Inventor | COULTER, Catherine, 38 Church Road
Gracehill
Ballymena
Co Antrim, IE,
JOHNSTON, Sean, M., 4360 Wismer Road
Doylestown
PA 18902, US,
SEYEDI, Farzaneh, 43 Ridgeview Lane
Mansfield
MA 02048, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/65 (2006.01) , C07C 237/26 (2006.01) | | Title | KRYSTALLINSKE SALTE AF (4S,4AS,5AR,12AS)-4-DIMETHYLAMINO-3,10,12,12A-TETRAHYDROXY-7-[(METHOXY(METHYL)AMINO)-METHYL]-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-NAPHTHACEN-2-CARBOXYLSYREAMID OG FREMGANGSMÅDER TIL ANVENDELSE DERAF | | Int. application no. | US2012037838 | | Int. publication no. | WO2012155146 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
